BioSpace News Archive

Smartlens, Inc., a clinical-stage ophthalmic technology company, has announced positive clinical results for miLens, a non-invasive, electronics-free, soft contact lens for monitoring intraocular pressure (IOP).

AOM Infusion, a leading specialty infusion provider focused on intravenous immunoglobulin, chronic inflammatory and specialty infusion therapy, announced that Keyur Mehta has been named Chief Executive Officer.

The Insight Partners published latest research report on “Small Molecule Drug Discovery Market Size Report, Share, Growth & Trends Forecast to 2027 - COVID-19 Impact and Global Analysis by Therapeutic Area; Process/Phase; and Geography”,

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is pleased to announce that VINIA®, the first product developed on its proprietary Bio-Plant CELLicitation platform, has been recognized as an Honorable mention in the Wellness category of Fast Company’s 2023 World Changing Ideas Awards.

Catailyst.ai, a leading provider of state-of-the-art data science tools, has announced a strategic partnership with Launchit Ventures Inc., a venture studio focused on advancing healthcare innovation. This collaboration aims to streamline the sales and marketing process, facilitate product development, and expand global product sales and customer acquisition.

EmergeOrtho—Triangle Region is pleased to announce the addition of Dr. Josh Hudgens to the expert orthopedic care team.

LifeLabs, a leading provider of laboratory testing and diagnostic services in Canada, is proud to announce the promotion of Dr. Cathy Ross to the position of Vice President of Medical and Quality Affairs.

Aquyre Biosciences, Inc. announced the appointment of F. Samuel Eberts III as Chief Executive Officer and Chairman of its Board of Directors.

TRACON Pharmaceuticals, Inc. (Nasdaq: TCON) announced today that it will report its first quarter 2023 financial and operating results after the close of U.S. financial markets on Wednesday, May 10, 2023.

Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that it will release its first quarter 2023 financial results after market close on Wednesday, May 10, 2023.